60
Participants
Start Date
September 20, 2024
Primary Completion Date
November 23, 2024
Study Completion Date
December 23, 2026
recombinant human follicle-stimulating hormone-CTP Fusion protein injection
IF Weight \> 60kg，150ug, H. Administer the drug once every 14 days for 64 weeks；IF Weight \>≤60kg，100ug, H. Administer the drug once every 14 days for 64 weeks
recombinant human follicle-stimulating hormone-CTP Fusion protein injection Placebo
0.5ml, H. Administer the drug once every 14 days for 64 weeks
Beijing Children's Hospital, Capital Medical University, Beijing
Peking Union Hospital, Chinese Academy of Medical Sciences, Beijing
Shengjing Hospital affiliated to China Medical University, Shenyang
Shanghai Children's Hospital, Shanghai
Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai
Affiliated Pediatric Hospital of Fudan University, Shanghai
Nanjing Children's Hospital, Nanjing
Anhui Children's Hospital, Hefei
Affiliated Hospital of Jining Medical College, Jining
Jiangxi Children's Hospital, Nanchang
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
Women and Children's Medical Center Affiliated to Guangzhou Medical University, Guangzhou
Shenzhen Children's Hospital, Shenzhen
Chengdu Women and Children's Central Hospital, Chengdu
Changchun GeneScience Pharmaceutical Co., Ltd.
INDUSTRY